NASDAQ:FBIO - Fortress Biotech SEC Filings & 10K Form

$1.83
-0.03 (-1.61 %)
(As of 09/18/2019 03:37 PM ET)
Today's Range
$1.80
Now: $1.83
$1.88
50-Day Range
$1.29
MA: $1.63
$1.96
52-Week Range
$0.49
Now: $1.83
$2.59
Volume10,647 shs
Average Volume449,914 shs
Market Capitalization$126.34 million
P/E RatioN/A
Dividend YieldN/A
Beta2.23

SEC Filings

Fortress Biotech (NASDAQ:FBIO) SEC Filings

DateFilerForm TypeView
08/23/2019
3:02 PM
Fortress Biotech (Filer)
Form 424B3
08/19/2019
7:01 AM
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
3:35 PM
Fortress Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/09/2019
3:32 PM
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
3:04 PM
Fortress Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2019
11:15 PM
Fortress Biotech (Filer)
Form EFFECT
07/19/2019
6:00 AM
Fortress Biotech (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2019
3:01 PM
Avgerinos George (Reporting)
Fortress Biotech (Issuer)
Form 4/A
06/28/2019
4:28 PM
Fortress Biotech (Filer)
Form S-3/A
06/20/2019
3:38 PM
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2019
4:06 PM
Fortress Biotech (Filed by)
MUSTANG BIO, INC. (Subject)
Form SC 13D/A
04/30/2019
6:27 AM
Fortress Biotech (Filer)
Form DEFA14A
04/30/2019
6:24 AM
Fortress Biotech (Filer)
Form DEF 14A
04/19/2019
3:19 PM
Checkpoint Therapeutics, Inc. (Subject)
Fortress Biotech (Filed by)
Form SC 13D/A
04/19/2019
3:18 PM
AVENUE THERAPEUTICS, INC. (Subject)
Fortress Biotech (Filed by)
Form SC 13D/A
04/19/2019
3:18 PM
Fortress Biotech (Filed by)
NATIONAL HOLDINGS CORP (Subject)
Form SC 13D/A
04/12/2019
3:11 PM
Fortress Biotech (Issuer)
WEISS MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
3:10 PM
Fortress Biotech (Issuer)
Klein Dov (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
3:10 PM
Fortress Biotech (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
3:09 PM
Fortress Biotech (Issuer)
LOBELL J JAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
3:09 PM
Fortress Biotech (Issuer)
Hoenlein Malcolm (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
3:08 PM
Fortress Biotech (Issuer)
Harvey Jimmie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
3:08 PM
Fortress Biotech (Issuer)
Rowinsky Eric K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2019
4:17 PM
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
3:09 PM
Fortress Biotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2019
2:01 PM
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2019
7:52 AM
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2019
6:52 AM
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2018
5:10 PM
Avgerinos George (Reporting)
Fortress Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:30 PM
Fortress Biotech (Issuer)
Hoenlein Malcolm (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:29 PM
Fortress Biotech (Issuer)
Harvey Jimmie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:28 PM
Fortress Biotech (Issuer)
LOBELL J JAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:27 PM
Fortress Biotech (Issuer)
Rowinsky Eric K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:26 PM
Fortress Biotech (Issuer)
Hunter Robyn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2018
3:15 PM
Fortress Biotech (Filed by)
NATIONAL HOLDINGS CORP (Subject)
Form SC 13D/A
11/20/2018
2:06 PM
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2018
10:27 AM
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2018
7:40 AM
Fortress Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2018
6:35 AM
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
3:17 PM
Fortress Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/20/2018
3:17 PM
Fortress Biotech (Filer)
Form S-3/A
07/06/2018
4:17 PM
Fortress Biotech (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/19/2018
3:15 PM
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2018
3:37 PM
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2018
3:29 PM
Fortress Biotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/20/2018
3:44 PM
Fortress Biotech (Filer)
Form PRE 14A
04/05/2018
4:18 PM
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2018
4:17 PM
Fortress Biotech (Filer)
Form 424B3
03/16/2018
7:00 AM
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2018
8:11 AM
Fortress Biotech (Filer)
Form D
Notice of Exempt Offering of Securities 
01/17/2018
8:19 AM
Fortress Biotech (Subject)
KATZ DARYL (Filed by)
Form SC 13G/A
12/18/2017
5:46 PM
Avgerinos George (Reporting)
Fortress Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2017
7:18 PM
Avgerinos George (Reporting)
Fortress Biotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2017
6:00 AM
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 9/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel